Fig. 7From: Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancerThe survival prediction ability of patients with different clinical characteristics of the signature. A-H Stratified analyses results of tumor stage, T, N, MBack to article page